Modification of histidine (B10) is the causative agent for a superactive form of insulin

Biochemical and Biophysical Research Communications

Volumn 290, Issue 2, 2002, Pages 775-777

  Wilchek, Meir ^a   Miron, Talia ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cyanogen bromide; His (B10); Insulin; Sepharose; Superactive

Indexed keywords

AMMONIUM BICARBONATE; AMMONIUM DERIVATIVE; ASPARTIC ACID; HISTIDINE; IMIDAZOLE DERIVATIVE; INSULIN; RESIN; SEPHAROSE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ARTICLE; CHEMICAL MODIFICATION; INSULIN BINDING; INSULIN RELEASE; PRIORITY JOURNAL;

EID: 0036297444     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.6253     Document Type: Article

References (14)

1. A soluble super-active form of insulin
2. Insulin-unresponsive tissues respond to superactive insulin-like material
3. Structure of a soluble super-active insulin is revealed by the nature of the complex between cyanogen-bromide-activated Sepharose and amines
4. Characterization of super-active insulin, prolactin and placental lactogen
5. An insulin derivative with biological activity greater than that of native insulin
6. A superactive insulin: [B10-aspartic acid]insulin (human)
7. The long acting human insulin analog HOE 901: Characteristics of insulin signaling in comparison to Asp(B10) and regular insulin
8. Engineering stability of the insulin monomer fold with application to structure-activity relationships
9. Recombinant-DNA-derived insulin analogues as potentially useful therapeutic agents
10. Insulins today and beyond
11. Sequence of a peptide susceptible to mixed-function oxidation. Probable cation binding site in glutamine synthetase
12. Sensitized photooxidation of histidine and its derivatives. Products and mechanism of the reaction
13. 2+
14. Super-active forms of placental lactogen and prolactin